-
Active Trials
-
Phase 3
-
Phase 2
-
Phase 1
-
Results Pending
📊
Pipeline Summary
Expected Approvals
FDA Decisions 2 upcoming PDUFA dates
Tavapadon Parkinson's disease (monotherapy and adjunct to levodopa) NDA
Pivekimab sunirine (PVEK) Blastic plasmacytoid dendritic cell neoplasm (BPDCN) BLA
Clinical Trials
Loading...